Histologic versus clinical remission in proliferative lupus nephritis

Nephrology Dialysis Transplantation

Volumn 32, Issue 8, 2017, Pages 1338-1344

  Malvar, Ana ^a   Pirruccio, Paola ^a   Alberton, Valeria ^a   Lococo, Bruno ^a   Recalde, Cecilia ^a   Fazini, Bernanda ^a   Nagaraja, Haikady ^b   Indrakanti, DIvya ^c   Rovin, Brad H ^c  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

activity index; chronicity index; kidney biopsy; lupus nephritis; outcomes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE;

ADULT; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; REPEAT PROCEDURE; TREATMENT RESPONSE; BIOPSY; COMPARATIVE STUDY; COMPLICATION; INFLAMMATION; PATHOLOGY;

ADULT; BIOPSY; FEMALE; HUMANS; INFLAMMATION; LUPUS NEPHRITIS; MALE; REMISSION INDUCTION; RENAL INSUFFICIENCY, CHRONIC;

EID: 85026893397     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv296     Document Type: Article

References (18)

1. Wofsy D, Hillson JL, Diamond B. Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials. Arthritis Rheum 2013; 65: 1586-1591
2. Rovin BH, Parikh SV, Alvarado A. The kidney biopsy in lupus nephritis: Is it still relevant? In: EM Ginzler, MA Dooley (eds). Systemic Lupus Erythematosus. Philadelphia: Elsevier, 2014, pp. 537-552
3. Hill GS, Delahouse M, Nochy D, et al. A newmorphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 2000; 58: 1160-1173
4. Hill GS, Delahousse M, Nochy D, et al. Predictive power of the second renal biopsy in lupus nephritis: Significance of macrophages. Kidney Int 2001; 59: 304-316
5. Hill GS, Delahousse M, Nochy D, et al. Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 2001; 60: 1893-1903
6. Hill GS, Delahousse M, Nochy D, et al. Outcome of relapse in lupus nephritis: Roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int 2002; 61: 2176-2186
7. Zickert A, Sundelin B, Svenungsson E, et al. Role of early repeated renal biopsies in lupus nephritis. Lupus Sci Med 2014; doi:10.1135/lupus-2014-000018
8. Alvarado A, Malvar A, Lococo B, et al. The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients. Lupus 2014; 23: 840-847
9. Singh A, Ghosh R, Kaur P, et al. Protocol renal biopsy in patients with lupus nephritis: A single center experience. Saudi J Kidney Dis Transpl 2014; 25: 801-807
10. Gunnarsson I, Sundelin B, Heimburger M, et al. Repeated renal biopsy in proliferative lupus nephritis-predictive role of serumC1q and albuminuria. J Rheumatol 2002; 29: 693-699
11. Askenazi D, Myones B, Kamdar A, et al. Outcomes of childrenwith proliferative lupus nephritis: The role of protocol renal biopsy. Pediatr Nephrol 2007; 22: 981-986
12. Ong LM, Hooi LS, Lim TO, et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 2005; 10: 504-510
13. Traitanon O, Avihingsanon Y, Kittikovit V, et al. Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: A prospective study. Lupus 2008; 17: 744-751
14. Austin HA, III, Muenz LR, Joyce KMet al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am JMed 1983; 75: 382-391
15. Tamirou F, D'Cruz D, Sangle S, et al. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis 2015; doi:10.1136/annrheumdis-2014-206897
16. Lent V, Harth J. Nephropathy in remnant kidneys: Pathological proteinuria after unilateral nephrectomy. J Urol 1994; 152: 312-316
17. Karlen J, Linne T, Wikstad I, et al. Incidence of microalbuminuria in children with pyelonephritic scarring. Pediatr Nephrol 1996; 10: 705-708
18. Parikh SV, Nagaraja HN, Hebert L, et al. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol 2014; 9: 279-284